Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (441-450 of 580) with videos related to

Pageof 58
Sort By:
Nature Communications|August 10, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistanceJulia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in miceChengwen Liu, Weiyi Peng, Chunyu Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
JCI Insight|March 30, 2017
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancerJulie E Bauman, Umamaheswar Duvvuri, William E Gooding, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Cancer Discovery|December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotypeKim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.
JCO Precision Oncology|July 10, 2024
Phase II Trial of Afatinib in Patients With <i>EGFR</i>-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol AScott N Gettinger, Zihe Song, Karen L Reckamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibJan C Brase, Robert F H Walter, Alexander Savchenko, et al.
Pageof 58

Showing results (441-450 of 580) with videos related to

Sort By:
Pageof 58
Nature Communications|August 10, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistanceJulia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in miceChengwen Liu, Weiyi Peng, Chunyu Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
JCI Insight|March 30, 2017
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancerJulie E Bauman, Umamaheswar Duvvuri, William E Gooding, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Cancer Discovery|December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotypeKim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.
JCO Precision Oncology|July 10, 2024
Phase II Trial of Afatinib in Patients With <i>EGFR</i>-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol AScott N Gettinger, Zihe Song, Karen L Reckamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibJan C Brase, Robert F H Walter, Alexander Savchenko, et al.
Pageof 58